Toxicologic Pathology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuchiya, T.
Right arrow Articles by Mutai, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuchiya, T.
Right arrow Articles by Mutai, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Toxicologic Pathology, Vol. 30, No. 4, 501-506 (2002)
DOI: 10.1080/01926230290105677

Skeletal Myopathy in Transgenic Mice Carrying Human Prototype c-Ha-ras Gene

Takayuki Tsuchiya

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan, Tsuchiya.Takayuki@ mf.m-pharma.co.jp

Kiyoshi Kobayashi

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Tetsuya Sakairi

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Kazuhiro Goto

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Miyoko Okada

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Fumiko Sano

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Jiro Sugimoto

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Tetsuo Morohashi

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Toshimi Usui

Central Institute of Experimental Animals, Miyamae-ku, Kawasaki 216-0001, Japan

Mamoru Mutai

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Skeletal myopathy was found in almost all-transgenic mice carrying the human prototype c-Ha-ras gene (rasH2 mouse). Microscopically, variation of the muscle fiber size, centrally placed nuclei, regenerating fibers, and interstitial fibrosis were evident; hyalinization and necrosis were sometimes observed in the skeletal muscle (femoralis and pectoralis) of the rasH2 mice. Inflammatory changes in the skeletal muscle or abnormality of adjacent peripheral nerve were not observed. The features were essentially similar to those of muscular dystrophy. Although the severity was relatively mild compared to 34-week-old rasH2 mice, the skeletal myopathy was also observed in younger male (10 weeks of age) rasH2 mice. In nontransgenic littermates, skeletal myopathy was not observed. The mRNA of human c-Ha-ras product was detected in femoral muscle from the rasH2 mice by RT-PCR. In conclusion, these data suggest that skeletal myopathy is occurring in almost all rasH2 mice. Integration of c-Ha- ras gene is thought to be crucial to pathogenesis of skeletal myopathy in the rasH2 mice. Further characterization of the muscular lesion and its pathogenesis are needed to explore the possibility of rasH2 mouse becoming a new model for muscular dystrophy.

Key Words: Skeletal muscle • muscular dystrophy • rasH2 mouse • ras gene • histopathology • spontaneous.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
M. Okamura, M. Moto, M. Muguruma, T. Ito, M. Jin, Y. Kashida, and K. Mitsumori
A 26-Week Carcinogenicity Study of 2-Amino-3-Methylimidazo[4,5-f]Quinoline in rasH2 Mice
Toxicol Pathol, February 1, 2006; 34(2): 199 - 205.
[Abstract] [Full Text] [PDF]